Covid-19: a new mechanism of immune resistance discovered
Bellinzona, January 31, 2022 – Not only vaccines and antibodies but also innate immunity, the first line of defense that plays a key role in pathogen resistance, plays its part against Sars-CoV-2 and its variants, including Omicron. This is the discovery published in Nature Immunology, the result of an international effort in which researchers from […]
Marcus Thelen nominated for a Life Science Switzerland (LS)2 Honorary membership
Bellinzona, January 28, 2022 – Marcus Thelen has been nominated by the LS2 section Molecular and Cellular Biosciences for a LS2 Honorary membership and selected by an internal committee of different board section members and junior LS2 members for his contributions to LS2 and his outstanding scientific career and achievements. Marcus Thelen has served the […]
Santiago González President of the Association of the Spanish scientists in Switzerland
Bellinzona, January 25, 2022 – Santiago González head of the Infection and Immunity laboratory at the IRB has been elected president of the association of Spanish scientists in Switzerland (ACECH), a non-profit organization created in November 2017 and formed by more than 250 Spanish researchers from all disciplines working in Switzerland. The association aims at […]
Gaia Antonini, Josipa Jerak and Pedro Ventura IRB Student awardees 2020-2021
On January 18, 2022, Josipa Jerak (Cellular Immunology Lab), Gaia Antonini (Systems Immunology Lab) and Pedro Ventura (Immune Mechanisms Lab) were announced as the grantees of the ninth IRB PhD Student Award. For their studies, Josipa and Pedro are enrolled at the ETHZ, while Gaia is enrolled at the Università della Svizzera italiana (USI). This […]
Reasons for rejecting the initiative to ban animal and human experimentation in Switzerland
Bellinzona, 13.01.2022 – On 13 February 2022, Swiss citizens will be asked to vote on a popular initiative calling for a complete ban on all animal and human experimentation in Switzerland. The initiative also calls for a ban, from 2024, on all new drugs and medical treatments that have been tested on animals or humans, […]
Science that Helps – History and prospects of biomedical research in Bellinzona
The book “Science that Helps – History and prospects of biomedical research in Bellinzona” tells the story of the first twenty years in the history of the Institute for Research in Biomedicine (IRB) and the Institute of Oncology Research (IOR) through the most important events, testimonies and reflections of people from the political and academic world, as well […]
Happy Holidays and a Happy New Year
A new cell analyser at IRB to celebrate the 25th anniversary of the Leonardo Foundation
Bellinzona, December 9th, 2021 – As part of its 25th anniversary celebrations, the Leonardo Foundation has decided to make a contribution to scientific research performed at the new biomedical research centre in Bellinzona with an important donation for the purchase of a new FACS Symphony S6 cell analyser, a fundamental device for research in the […]
Roger Geiger selected to the EMBO Young Investigator programme
Bellinzona, December 10, 2021 – The European Molecular Biology Organisation (EMBO) has selected Roger Geiger, group leader at the Institute for Research in Biomedicine (IRB, affiliated to USI Università della Svizzera italiana), to the EMBO Young Investigator Programme in recognition of his scientific excellence. Geiger is the second IRB life scientist to join EMBO in […]
Interplay of Dna2 and RPA in DNA metabolism, a Nature Communications paper
Bellinzona, December 2nd, 2021 – DNA end resection is required for accurate processing of broken DNA. In a paper published in Nature Communications, IRB researchers Acharya, Cejka and colleagues investigated the interplay of the Dna2 nuclease and the single strand DNA binding protein RPA in DNA end resection. RPA has a strong affinity to ssDNA, […]
